Lilly Eyes More Cancer Deals, but Wary of CAR-T, Gene Therapy Lilly Eyes More Cancer Deals, but Wary of CAR-T, Gene Therapy

Eli Lilly and Co remains in the hunt for cancer drugs even after announcing an $8 billion purchase of Loxo Oncology this week, but it plans to remain on the sidelines when it comes to two of the hottest areas of drug development.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news